F. AKSOY Et Al. , "THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT," APASL 2017 , Shangai, China, pp.715-716, 2017
AKSOY, F. Et Al. 2017. THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT. APASL 2017 , (Shangai, China), 715-716.
AKSOY, F., KAYA, S., KARAKOÇ, H. N., YILMAZ, G., ATALAR, S., & KÖKSAL, İ., (2017). THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT . APASL 2017 (pp.715-716). Shangai, China
AKSOY, FİRDEVS Et Al. "THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT," APASL 2017, Shangai, China, 2017
AKSOY, FİRDEVS Et Al. "THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT." APASL 2017 , Shangai, China, pp.715-716, 2017
AKSOY, F. Et Al. (2017) . "THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT." APASL 2017 , Shangai, China, pp.715-716.
@conferencepaper{conferencepaper, author={FİRDEVS AKSOY Et Al. }, title={THE IMPORTANCE OF ANTIVIRAL PROPHYLAXIS AGAINST HEPATITIS B VIRUS IN PATIENTS UNDER IMMUNOSUPPRESSIVE TREATMENT}, congress name={APASL 2017}, city={Shangai}, country={China}, year={2017}, pages={715-716} }